Comparative toxicity on leukocytes and platelets of two regimens of CCNU: the relationship between maximum dose and optimum dose.
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects*; D001943:Breast Neoplasms / Q000097:blood / Q000473:pathology; D002283:Carcinoma, Bronchogenic / Q000097:blood / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000188:drug therapy; D003510:Cyclohexanes / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D005909:Glioblastoma / Q000097:blood / Q000188:drug therapy; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects*; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000139:chemically induced
D003510:Cyclohexanes; D009607:Nitrosourea Compounds